Topical use of ozone effectively alleviates the acute symptoms and quality of life of patients with moderate to severe bullous pemphigoid: a randomized controlled trial†

Affiliations

Li Li: Department of Dermatology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi030001, China
Sang Li-Yun: Department of Dermatology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi030001, China
Zhang Wen-Guang: Department of Nursing, First Hospital of Shanxi Medical University, Taiyuan, Shanxi030001, China
Wang Tong: School of Public Health, Shanxi Medical University, Taiyuan, Shanxi030001, China
Guo Shu-Ping: Department of Dermatology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi030001, China
Cui Hong-Zhou: Department of Dermatology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi030001, China
Liu Hong-Ye: Department of Dermatology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi030001, China

Abstract

To evaluate the adjuvant treatment of acute stage symptoms and quality of life of patients with bullous pemphigoid (BP) with ozone.